Disseminated superficial actinic porokeratosis (DSAP) is a severe chronic autosomal dominant cutaneous disorder with high genetic heterogeneity. mevalonate kinase, (MVK) a gene know to play an important role in regulation of calcium-induced keratinocyte differentiation and proliferation, has recently been suggested as the disease-causing gene for DSAP. Here we report a direct sequencing analysis of this gene in 3 DSAP families, 6 sporadic cases, and 100 unrelated healthy controls. We detected a heterozygous T to A transition at nucleotide 205 in exon 3 of MVK gene in one familial case. This mutation will result in an amino acid change at codon 69 (P.Ser69Thr), which is from a serine codon (TCA) to a threonine codon (ACA). No such mutation was detected in the unaffected family members or the 100 unrelated healthy controls. Our results demonstrated a novel missense mutation in MVK gene. This will be valuable for the diagnosis of DSAP as well as for genetic counseling and prenatal diagnosis of affected families.
This is a preview of subscription content, log in to check access.
We would like to thank the patients for participating in the study. This study was funded by the National Natural Youth Science Foundation (81101185) and Anhui Provincial Natural Science Foundation in year 2015.
Conflict of interest
The authors have no financial conflict of interest.
Liu P, Zhang S, Yao Q et al (2008) Identification of a genetic locus for autosomal dominant disseminated superficial actinic porokeratosis on chromosome 1p31.3–p31.1. Hum Genet 123:507–513PubMedCrossRefGoogle Scholar
Xia JH, Yang YF, Deng H et al (2000) Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2–24.1. J Invest Dermatol 114:1071–1074PubMedCrossRefGoogle Scholar
Zhang ZH, Niu ZM, Yuan WT et al (2005) A mutation in SART3 gene in a Chinese pedigree with disseminated superficial actinic porokeratosis. Br J Dermatol 152:658–663PubMedCrossRefGoogle Scholar
Xia K, Deng H, Xia JH et al (2002) A novel locus (DSAP2) for disseminated superficial actinic porokeratosis maps to chromosome 15q25.1–26.1. Br J Dermatol 147:650–654PubMedCrossRefGoogle Scholar
Luan J, Niu Z, Zhang J et al (2011) A novel locus for disseminated superficial actinic porokeratosis maps to chromosome 16q24.1–24.3. Hum Genet 129:329–334PubMedCrossRefGoogle Scholar
Frank J, van Geel M, van Steensel MA (2007) Loss of heterozygosity studies on chromosome 12q in disseminated superficial actinic porokeratosis: lessons to be learned. J Invest Dermatol 127:2058–2059PubMedCrossRefGoogle Scholar
Zhang Z, Niu Z, Yuan W et al (2004) Fine mapping and identification of a candidate gene SSH1 in disseminated superficial actinic porokeratosis. Hum Mutat 24(5):438PubMedCrossRefGoogle Scholar
Zhou Y, Liu J, Fu X et al (2013) Identification of three novel frameshift mutations of the MVK gene in four Chinese families with disseminated superficial actinic porokeratosis. Br J Dermatol 169(1):193–195PubMedCrossRefGoogle Scholar
Zhang SQ, Jiang T, Li M et al (2012) Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis. Nat Genet 44:1156–1160PubMedCrossRefGoogle Scholar
Dai J, Chen M, Fu X et al (2013) Mutation analysis of the MVK gene in Chinese patients with disseminated superficial actinic porokeratosis. J Dermatol Sci 72(3):320–322PubMedCrossRefGoogle Scholar
Bouwstra JA, Ponec M (2006) The skin barrier in healthy and diseased state Biochim. Biophys Acta 1758:2080–2095CrossRefGoogle Scholar
Zhao Y, Gartner U, Smith FJ, McLean WH (2011) Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. J Invest Dermatol 131:1045–1052PubMedCrossRefGoogle Scholar